NPI: 1962823211 · NEW ORLEANS, LA 70127 · Pharmacist · NPI assigned 01/03/2014
Authorized official GRIFFIN, MICHAEL controls 20+ related entities in our dataset. Read more
| Authorized Official | GRIFFIN, MICHAEL (CEO) |
| NPI Enumeration Date | 01/03/2014 |
Other providers sharing the same authorized official: GRIFFIN, MICHAEL
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 59,398 | $1.32M |
| 2019 | 45,897 | $1.50M |
| 2020 | 40,352 | $1.44M |
| 2021 | 38,418 | $1.52M |
| 2022 | 50,402 | $1.69M |
| 2023 | 84,080 | $2.10M |
| 2024 | 64,143 | $1.80M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| T1015 | Clinic visit/encounter, all-inclusive | 112,118 | 72,774 | $10.92M |
| H2020 | Therapeutic behavioral services, per diem | 4,969 | 2,095 | $436K |
| 99050 | 1,701 | 1,358 | $12K | |
| 98960 | 330 | 84 | $3K | |
| 99051 | 104 | 70 | $809.51 | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 57,807 | 39,438 | $332.78 |
| 3044F | 663 | 551 | $190.00 | |
| 81002 | 8,142 | 5,270 | $157.21 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3,628 | 2,609 | $138.67 |
| 3008F | 29,921 | 22,054 | $101.10 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 12,361 | 8,570 | $29.40 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 14,231 | 9,106 | $24.83 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 9,315 | 5,923 | $18.26 |
| 92551 | 4,155 | 2,565 | $8.27 | |
| 85018 | 5,390 | 3,559 | $4.72 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3,868 | 2,912 | $2.77 |
| 99173 | 4,728 | 2,902 | $1.91 | |
| 90671 | 825 | 583 | $0.00 | |
| 81025 | 1,002 | 700 | $0.00 | |
| 90715 | 45 | 27 | $0.00 | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,330 | 876 | $0.00 |
| 90670 | 2,657 | 2,032 | $0.00 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5,855 | 4,208 | $0.00 |
| 90832 | Psychotherapy, 30 minutes with patient | 4,855 | 1,934 | $0.00 |
| 90710 | 252 | 157 | $0.00 | |
| 3077F | 1,497 | 1,154 | $0.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2,127 | 1,576 | $0.00 |
| 1160F | 15,376 | 11,132 | $0.00 | |
| 90837 | Psychotherapy, 53 minutes with patient | 155 | 83 | $0.00 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 455 | 359 | $0.00 |
| 90749 | 585 | 261 | $0.00 | |
| 3078F | 2,552 | 2,000 | $0.00 | |
| 90633 | 1,815 | 1,222 | $0.00 | |
| 90473 | 261 | 217 | $0.00 | |
| 90649 | 216 | 72 | $0.00 | |
| 83037 | 5,092 | 3,550 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 382 | 279 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 69 | 56 | $0.00 |
| 90734 | 128 | 81 | $0.00 | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 45 | 33 | $0.00 |
| 90648 | 483 | 391 | $0.00 | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | 21 | 12 | $0.00 |
| 90658 | 411 | 318 | $0.00 | |
| 90655 | 124 | 100 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 63 | 49 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 482 | 342 | $0.00 |
| 80061 | Lipid panel | 86 | 51 | $0.00 |
| 99188 | 90 | 70 | $0.00 | |
| 1159F | 599 | 416 | $0.00 | |
| 83655 | 211 | 164 | $0.00 | |
| 90700 | 193 | 150 | $0.00 | |
| 90707 | 206 | 113 | $0.00 | |
| 1039F | 22 | 13 | $0.00 | |
| 96160 | 156 | 133 | $0.00 | |
| 4004F | 1,521 | 1,117 | $0.00 | |
| 86318 | 20 | 12 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 43 | 34 | $0.00 |
| 87799 | 237 | 151 | $0.00 | |
| 90838 | 98 | 75 | $0.00 | |
| 87481 | 237 | 151 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 620 | 448 | $0.00 |
| 82274 | 57 | 45 | $0.00 | |
| 87512 | 237 | 151 | $0.00 | |
| 90791 | Psychiatric diagnostic evaluation | 61 | 27 | $0.00 |
| 86703 | 30 | 14 | $0.00 | |
| 11721 | 60 | 43 | $0.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 14 | 14 | $0.00 |
| 3079F | 2,546 | 2,004 | $0.00 | |
| 90686 | 676 | 495 | $0.00 | |
| 82962 | 6,994 | 4,783 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 2,017 | 1,314 | $0.00 |
| 3351F | 6,548 | 4,868 | $0.00 | |
| 1036F | 6,601 | 4,845 | $0.00 | |
| 81099 | 5,549 | 3,577 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1,608 | 1,147 | $0.00 |
| 3074F | 3,510 | 2,751 | $0.00 | |
| 99407 | 120 | 87 | $0.00 | |
| 90744 | 746 | 562 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,055 | 593 | $0.00 |
| 4037F | 716 | 481 | $0.00 | |
| 3075F | 733 | 569 | $0.00 | |
| 90696 | 152 | 80 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 82 | 62 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 212 | 123 | $0.00 |
| 81001 | 226 | 160 | $0.00 | |
| 90474 | 159 | 129 | $0.00 | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4,266 | 3,239 | $0.00 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 18 | 14 | $0.00 |
| 90680 | 1,594 | 1,234 | $0.00 | |
| 90698 | 1,115 | 891 | $0.00 | |
| 1034F | 1,523 | 1,094 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 460 | 319 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 870 | 541 | $0.00 |
| 90651 | 633 | 436 | $0.00 | |
| 90697 | 335 | 249 | $0.00 | |
| G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 175 | 168 | $0.00 |
| 90619 | 264 | 178 | $0.00 | |
| 4000F | 152 | 115 | $0.00 | |
| 90656 | 105 | 86 | $0.00 | |
| S8110 | Peak expiratory flow rate (physician services) | 76 | 53 | $0.00 |
| 3353F | 549 | 403 | $0.00 | |
| 99381 | 280 | 181 | $0.00 | |
| 90688 | 46 | 41 | $0.00 | |
| 90716 | 215 | 117 | $0.00 | |
| 3080F | 499 | 375 | $0.00 | |
| 90647 | 29 | 26 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 51 | 25 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 71 | 43 | $0.00 |
| 90620 | 54 | 48 | $0.00 | |
| 87430 | 175 | 136 | $0.00 | |
| 90834 | Psychotherapy, 45 minutes with patient | 109 | 69 | $0.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 144 | 90 | $0.00 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 450 | 258 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 16 | 13 | $0.00 |
| 99385 | 30 | 27 | $0.00 | |
| 90677 | 104 | 77 | $0.00 | |
| 90654 | 96 | 66 | $0.00 | |
| 99406 | 73 | 53 | $0.00 | |
| 3352F | 117 | 84 | $0.00 | |
| 90723 | 48 | 42 | $0.00 | |
| 3354F | 21 | 18 | $0.00 | |
| 96127 | 17 | 13 | $0.00 | |
| 36416 | 105 | 70 | $0.00 | |
| 2000F | 67 | 27 | $0.00 | |
| 99441 | 31 | 13 | $0.00 | |
| 81000 | 18 | 13 | $0.00 | |
| 0001A | 12 | 12 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 22 | 13 | $0.00 |
| 99000 | 16 | 13 | $0.00 |